The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded an increase of 10.14%. However, over the last six months, the performance has been weaker by 272.55%. The price of CAPR increased 7.95% over the last 30 days. And in the last five days, it has surged by 4.61%.
Capricor Therapeutics Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $23.40 on 10/15/24, while the lowest price for the same duration was marked at $3.52 on 08/07/24.
52-week price history of CAPR Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Capricor Therapeutics Inc’s current trading price is -35.04% away from its 52-week high, while its distance from the 52-week low is 331.82%. The stock’s price range during this period has varied between$3.52 and $23.40. The Capricor Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.57 million for the day, a figure considerably lower than their average daily volume of 1.21 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Capricor Therapeutics Inc (CAPR) has experienced a quarterly decline of -29.17% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 691.15M and boasts a workforce of 102 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 15.01, with a change in price of +10.96. Similarly, Capricor Therapeutics Inc recorded 2,561,612 in trading volume during the last 100 days, posting a change of +258.49%.
CAPR’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CAPR stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.
CAPR Stock Stochastic Average
Capricor Therapeutics Inc’s raw stochastic average for the past 50 days is presently 34.71%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 74.87%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 58.46% and 54.63%, respectively.
